KalVista Pharmaceuticals Appoints William C. Fairey to Board of DirectorsBusiness Wire • 7 days agoKalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today...